But its important to note that responses can vary from person to person and any significant changes in energy levels should be discussed with your healthcare provider
Wegovy is a GLP-1 receptor agonist (once-weekly injection) that produces about 15% body weight loss, while Contrave is an oral pill combining naltrexone and bupropion that typically produces 5-8% loss
current data support an optical and functional effect driven by weight loss and metabolic improvement. Any perceived size increase should be considered a cosmetic byproduct of successful weight reduction, not a primary treatment goal or guaranteed outcome. Prescribing decisions for Semaglutide should remain grounded in its approved indications (type 2 diabetes and obesity) and wellcharacterized riskbenefit profile, not in viral sexual sideeffect narratives. Men who experience sexual dysfunction, genital pain, or unexpected swelling while on Semaglutide should seek medical evaluation, as these symptoms may signal other conditions that require specific management
It works best as part of a long-term plan
Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling
This can be challenging due to appetite changes from semaglutide, so working with a healthcare professional whos knowledgeable in nutritionbe it your provider (such as that through Ro) or a registered dietitiancan help you put a plan in place
